Free tool
FAERS Monitor: Ablysinol
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 207987 or its brand name (Ablysinol, Dehydrated Alcohol). Reports on generic versions are filed under their own applications.
Reports
27,075
Serious
25,838
95% of reports
Hospitalization
8,718
Death reported
15,214
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- toxicity to various agents6,095
- completed suicide5,439
- drug abuse5,341
- overdose1,906
- death1,608
- intentional overdose1,554
- suicide attempt1,374
- cardio-respiratory arrest1,349
- somnolence959
- drug dependence932
- drug interaction907
- coma867
- intentional product misuse866
- substance abuse843
- cardiac arrest746
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 241 |
| 2005 | 262 |
| 2006 | 264 |
| 2007 | 415 |
| 2008 | 440 |
| 2009 | 474 |
| 2010 | 575 |
| 2011 | 516 |
| 2012 | 438 |
| 2013 | 520 |
| 2014 | 481 |
| 2015 | 531 |
| 2016 | 619 |
| 2017 | 2,140 |
| 2018 | 1,714 |
| 2019 | 2,118 |
| 2020 | 2,655 |
| 2021 | 1,650 |
| 2022 | 2,393 |
| 2023 | 2,567 |
| 2024 | 2,159 |
| 2025 | 2,074 |
| 2026 | 1,829 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,027,084 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| substance abuseSignal | 843 | 89.6 | 83.5 | 66,178 |
| completed suicideSignal | 5,439 | 54.2 | 52.8 | 266,353 |
| drug abuseSignal | 5,341 | 53.2 | 51.9 | 256,938 |
| toxicity to various agentsSignal | 6,095 | 29.1 | 28.4 | 160,621 |
| cardio-respiratory arrestSignal | 1,349 | 25.9 | 24.5 | 31,244 |
| intentional overdoseSignal | 1,554 | 19.3 | 18.3 | 26,321 |
| suicide attemptSignal | 1,374 | 18.0 | 17.1 | 21,590 |
| comaSignal | 867 | 14.4 | 13.5 | 10,615 |
| intentional product misuseSignal | 866 | 7.8 | 7.3 | 5,056 |
| cardiac arrestSignal | 746 | 7.1 | 6.6 | 3,865 |
| overdoseSignal | 1,906 | 6.9 | 6.6 | 9,654 |
| drug dependenceSignal | 932 | 4.5 | 4.2 | 2,559 |
| drug interactionSignal | 907 | 4.5 | 4.2 | 2,437 |
| somnolenceSignal | 959 | 3.7 | 3.5 | 1,907 |
| death | 1,608 | 1.5 | 1.4 | 234 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.